日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy

TLR5 激动剂增强抗肿瘤免疫力并克服对免疫检查点治疗的耐药性

Caleb Gonzalez, Sarah Williamson, Seth T Gammon, Sarah Glazer, Joon Haeng Rhee, David Piwnica-Worms

Nucleoside Diphosphate Kinase-3 (NME3) Enhances TLR5-Induced NF κ B Activation

核苷二磷酸激酶 3 (NME3) 增强 TLR5 诱导的 NF κ B 活化

Kelly Flentie, Caleb Gonzalez, Brandon Kocher, Yue Wang, Hongtu Zhu, Jayne Marasa, David Piwnica-Worms